WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study â€“ Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months

Colin Hill

doi:10.1016/s1569-1993(15)30090-4

WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study â€“ Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months

Colin Hill

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Cystic Fibrosis
DOIs	https://doi.org/10.1016/s1569-1993(15)30090-4
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cystic fibrosis
Medicine
Inflammation
Long-term potentiation
Gastroenterology
Internal medicine
Intestinal failure
Parenteral nutrition
Receptor

Access to Document

10.1016/s1569-1993(15)30090-4

https://openalex.org/W1025295781Licence: CC BY-NC-ND

Cite this

@article{ccc14738e6124a92893511806af81211,

title = "WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study {\^a}€“ Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months",

keywords = "Cystic fibrosis, Medicine, Inflammation, Long-term potentiation, Gastroenterology, Internal medicine, Intestinal failure, Parenteral nutrition, Receptor",

author = "Colin Hill",

year = "2015",

doi = "10.1016/s1569-1993(15)30090-4",

language = "English",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study â€“ Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months

AU - Hill, Colin

PY - 2015

Y1 - 2015

KW - Cystic fibrosis

KW - Medicine

KW - Inflammation

KW - Long-term potentiation

KW - Gastroenterology

KW - Internal medicine

KW - Intestinal failure

KW - Parenteral nutrition

KW - Receptor

U2 - 10.1016/s1569-1993(15)30090-4

DO - 10.1016/s1569-1993(15)30090-4

M3 - Article

SN - 1569-1993

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

ER -